VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.
University of Nebraska Medical Center, Omaha.
Arthritis Care Res (Hoboken). 2023 Aug;75(8):1648-1658. doi: 10.1002/acr.25053. Epub 2023 Jan 25.
OBJECTIVE: To examine temporal trends in all-cause and cause-specific mortality in patients with rheumatoid arthritis (RA) in the Veterans Health Administration (VHA). METHODS: We conducted a matched cohort study in the VHA from January 1, 2000 to December 31, 2017. Incident RA patients were matched up to 1:10 on age, sex, and VHA enrollment year to non-RA patients, then followed until death or end of study period. Cause of death was obtained from the National Death Index. Multivariable Cox regression models stratified by RA diagnosis years were used to examine trends in RA-related risk of all-cause and cause-specific mortality. RESULTS: Among 29,779 incident RA patients (matched to 245,226 non-RA patients), 9,565 deaths occurred. RA patients were at increased risk of all-cause (adjusted hazard ratio [HR ] 1.23 [95% confidence interval (95% CI) 1.20-1.26]), cardiovascular (HR 1.19 [95% CI 1.14-1.23]), cancer (HR 1.19 [95% CI 1.14-1.24]), respiratory (HR 1.46 [95% CI 1.38-1.55]), and infection-related mortality (HR 1.59 [95% CI 1.41-1.80]). Interstitial lung disease was the cause of death most strongly associated with RA (HR 3.39 [95% CI 2.88-3.99]). Nearly 70% of excess deaths in RA were attributable to cardiopulmonary disease. All-cause mortality risk related to RA was lower among those diagnosed during 2012-2017 (HR 1.10 [95% CI 1.05-1.15]) compared to 2000-2005 (HR 1.31 [95% CI 1.26-1.36]), but still higher than for non-RA controls (P < 0.001). Cause-specific mortality trends were similar. CONCLUSION: Excess RA-related mortality was driven by cardiovascular, cancer, respiratory, and infectious causes, particularly cardiopulmonary diseases. Although our findings support that RA-related mortality risk is decreasing over time, a mortality gap remains for all-cause and cause-specific mortality in RA.
目的:在退伍军人健康管理局(VA)中研究类风湿关节炎(RA)患者全因和病因特异性死亡率的时间趋势。
方法:我们在 VA 中进行了一项匹配队列研究,时间范围为 2000 年 1 月 1 日至 2017 年 12 月 31 日。将新诊断为 RA 的患者与年龄、性别和 VA 登记年份相匹配的非 RA 患者按 1:10 的比例进行匹配,然后随访至死亡或研究期末。通过国家死亡索引获得死因。使用多变量 Cox 回归模型,按 RA 诊断年份分层,以研究 RA 相关全因和病因特异性死亡率的趋势。
结果:在 29779 例新发 RA 患者(与 245226 例非 RA 患者相匹配)中,有 9565 例死亡。RA 患者全因死亡率(调整后的危险比[HR]1.23[95%置信区间(95%CI)1.20-1.26])、心血管疾病(HR 1.19[95%CI 1.14-1.23])、癌症(HR 1.19[95%CI 1.14-1.24])、呼吸疾病(HR 1.46[95%CI 1.38-1.55])和感染相关死亡率(HR 1.59[95%CI 1.41-1.80])均升高。间质性肺病是与 RA 相关性死亡的最主要原因(HR 3.39[95%CI 2.88-3.99])。RA 患者中约 70%的超额死亡归因于心肺疾病。与 2000-2005 年(HR 1.31[95%CI 1.26-1.36])相比,2012-2017 年期间诊断出的 RA 患者的全因死亡率风险(HR 1.10[95%CI 1.05-1.15])较低,但仍高于非 RA 对照组(P<0.001)。病因特异性死亡率趋势相似。
结论:心血管疾病、癌症、呼吸疾病和传染病是导致 RA 相关死亡率增加的主要原因,尤其是心肺疾病。尽管我们的研究结果表明 RA 相关死亡率风险随时间降低,但 RA 的全因和病因特异性死亡率仍存在差距。
Arthritis Care Res (Hoboken). 2023-4
Arthritis Care Res (Hoboken). 2016-1
J Rheumatol. 2008-6
Arthritis Care Res (Hoboken). 2023-4
Arthritis Care Res (Hoboken). 2010-3
Arthritis Care Res (Hoboken). 2017-12-6
Curr Treatm Opt Rheumatol. 2024-12
Am J Physiol Lung Cell Mol Physiol. 2025-1-1
Semin Arthritis Rheum. 2025-2
Rheumatology (Oxford). 2021-1-5
Arthritis Care Res (Hoboken). 2020-10
Clin Rheumatol. 2018-10-2